Pentixapharm Holding AGXTER:PTP +12.86%12 PB Ratio is 1.83 as of Jun. 26, 2026, which is 33% above its 10-year median of 1.38. GuruFocus rates XTER:PTP with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 1,233 Biotechnology companies, Pentixapharm Holding AG ranks better than 68.94% on this metric.
The historical rank and industry rank for Pentixapharm Holding AG's PB Ratio or its related term are showing as below:
XTER:PTP'
s PB Ratio Range Over the Past 10 Years
Min: 0.87 Med: 1.38 Max: 2.11
Current: 1.62
During the past 5 years, Pentixapharm Holding AG's highest PB Ratio was 2.11. The lowest was 0.87. And the median was 1.38.
XTER:PTP's PB Ratio is ranked better than 68.94% of 1233
companies
in the Biotechnology industry
Industry Median: 2.8
vs XTER:PTP: 1.62
During the past 12 months, Pentixapharm Holding AG's average Book Value Per Share Growth Rate was -29.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -3.00% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Pentixapharm Holding AG was 21.70% per year. The lowest was -3.00% per year. And the median was 9.35% per year.
Back to Basics: PB Ratio
Pentixapharm Holding AG (XTER:PTP) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Pentixapharm Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pentixapharm Holding AG PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where Pentixapharm Holding AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Pentixapharm Holding AG (XTER:PTP) has a PB Ratio of 1.83 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pentixapharm Holding AG and its competitors. This is 33% above median its historical median of 1.38. Over the past decade, Pentixapharm Holding AG's PB Ratio has ranged from 0.87 to 2.11. According to the industry distribution chart, Pentixapharm Holding AG ranks #383 out of 1233 companies in the Biotechnology industry, placing it in the top 31.1%.
Is Pentixapharm Holding AG's PB Ratio too high?
Pentixapharm Holding AG's current PB Ratio of 1.83 is 33% above median its 10-year median of 1.38. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 2.11. The Biotechnology industry median PB Ratio is 2.80. Pentixapharm Holding AG's value of 1.83 is 34.6% below this industry median. Based on the distribution chart, Pentixapharm Holding AG ranks #383 out of 1233 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Pentixapharm Holding AG has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pentixapharm Holding AG ranks #383 out of 1233 companies for PB Ratio. This puts Pentixapharm Holding AG in the upper half of its industry. The industry median PB Ratio is 2.80. Pentixapharm Holding AG's value of 1.83 is 34.6% below this benchmark. Historically, Pentixapharm Holding AG's own PB Ratio has ranged from 0.87 to 2.11 over the past decade. While the company's 10-year median is 1.38 vs. the industry median of 2.80, Pentixapharm Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.80, based on 1,233 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pentixapharm Holding AG's current PB Ratio of 1.83 is 34.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pentixapharm Holding AG and its competitors. For the Biotechnology industry, the median PB Ratio is 2.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pentixapharm Holding AG's current PB Ratio is 1.83, which is 33% above median its own 10-year median of 1.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (XTER:PTP) has a current PB Ratio of 1.83. The current PB Ratio is 1.83, which is 33% above median its 10-year median of 1.38 and 34.6% below the Biotechnology industry median of 2.80. Pentixapharm Holding AG's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Pentixapharm Holding AG (XTER:PTP), the current PB Ratio is 1.83 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
12GF Score
Get the complete analysis for XTER:PTP
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:PTP has been successfully added to your 
